mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.1 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.1 |